Alliance Foundation Trials.

No events began in the chosen period. Widen it, or reset.

• FDA Structural
  FDA granted approval for the FAYUVI treatment on October 7, 2026.
  Moves Alliance Foundation Trials

  07:01
• Natera Structural
  Steven Chapman was appointed as the CEO of Natera on August 14, 2025.
  Moves Alliance Foundation Trials

  Tue 10:03
• Hoffmann-La Roche Operational
  Roche, a representative of Hoffmann-La Roche, has been appointed as a city commissioner in Cambridge.
  Moves Alliance Foundation Trials

  05:45

• Otto Metzger Structural

  Otto Metzger serves as the Principal Investigator for Alliance Foundation Trials (PATINA).

  Some supportJun 25
  Alliance Foundation Trials → Otto Metzger

  Otto Metzger → Alliance Foundation Trials
• Natera Structural

  Natera provides MRD monitoring services used in Alliance Foundation Trials' clinical studies.

  Some supportTue 04:30
  Alliance Foundation Trials → Natera

  Natera → Alliance Foundation Trials
• FDA Structural

  FDA approval provided regulatory validation to Alliance Foundation Trials.

  Some supportJun 25
  Alliance Foundation Trials → FDA

  FDA → Alliance Foundation Trials
• Hoffmann-La Roche Operational

  Genentech co-funds and collaborates on the trial.

  Some supportTue 04:30
  Alliance Foundation Trials → Hoffmann-La Roche

  Hoffmann-La Roche → Alliance Foundation Trials
• Evanthia Galanis Structural

  Evanthia Galanis serves as the President of Alliance Foundation Trials.

  Some supportJun 25
  Alliance Foundation Trials → Evanthia Galanis

  Evanthia Galanis → Alliance Foundation Trials